Identification of Cell Nonautonomous DNA Damage Responses in the Tumor Microenvironment That Contribute to Cancer Therapy Resistance

doi 10.21236/ada601305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-Cancer Therapy

Frontiers in Oncology
Cancer ResearchOncology
2018English

Tumor Plasticity Driven by Spatial Micro-Heterogeneity in the Tumor Microenvironment Contributes to Therapy Resistance

Journal of Carcinogenesis & Mutagenesis
2014English

A New Approach to Cancer Therapy: The Tumor Microenvironment as Target

2013English

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

The Role of ATM in DNA Damage Responses and Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Candidate Markers That Associate With Chemotherapy Resistance in Breast Cancer Through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs)

PLoS ONE
Multidisciplinary
2013English

VEGF165 Expression in the Tumor Microenvironment Influences the Differentiation of Bone Marrow-Derived Pericytes That Contribute to the Ewing’s Sarcoma Vasculature

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2008English

Germ Cell Apoptosis and DNA Damage Responses

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy